Get started
Work

Supplemental Figure 3 from Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma

Year: 2023
Type: supplementary-materials
Abstract: Flow cytometric analysis of NK, NK T cell and Treg subpopulations.
DOI: 10.1158/1078-0432.22481073
Authors: Joseph M. Tuscano, Christina Poh, Paul Kaesberg, Guilluame Luxardi, Alexander Merleev, Alina Marusina, Ann Brunson, Aaron Rosenberg, Brian Jonas, Emanual Maverakis
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362432390
Cites:
Cited by:
Related to: 10